SCHEMBL5149840

SCHEMBL5149840

CCOC(=O)OC(C)[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6564563 0.83
SCHEMBL187616 0.82
SCHEMBL28404629 0.82 ALDH1A1 (0.60)
SCHEMBL12315103 0.82 ALDH1A1 (0.60)
SCHEMBL7870958 0.81 HCAR2 (0.38)
SCHEMBL1111518 0.80
SCHEMBL14504458 0.79 ALDH1A1 (0.50)
SCHEMBL2986945 0.78 ALDH1A1 (0.55)
SCHEMBL9354654 0.78
SCHEMBL2984393 0.78 ALDH1A1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2341047-B1 CYCLOHEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF TORAY INDUSTRIES (JP) 2014-10-15 EP claimed
US-7304079-B2 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2007-12-04 US claimed
US-20070093530-A1 SUBSTITUTED INDOLEALKANOIC ACIDS THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY, LLC 2007-04-26 US claimed
US-7105514-B2 Substituted indolealkanoic acids THE INSTITUTE FOR DIBETES DISCOVERY LLC (US) 2006-09-12 US claimed
US-5166212-A Hypotensive agents, analgesics CIBA-GEIGY CORPORATION (US) 1992-11-24 US claimed
US-5021430-A Enkephalinase inhibitors, analgesics, hypotensives CIBA-GEIGY CORPORATION (US) 1991-06-04 US claimed
US-4939261-A ANALGESICS, ANTIDEPRESSANTS, HYPOTENSIVE AGENTS, NEUROLEPTIC AGENTS CIBA-GEIGY CORPORATION (US) 1990-07-03 US claimed
US-4914129-A Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups CIBA-GEIGY CORPORATION (US) 1990-04-03 US claimed
US-4889869-A ANTIALDOSTERONISM AGENTS CIBA-GEIGY CORPORATION (US) 1989-12-26 US claimed
US-4758584-A Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups CIBA-GEIGY CORPORATION (US) 1988-07-19 US claimed
EP-0225292-A2 Certain N-substituted butyramide derivatives CIBA-GEIGY AG (CH) 1987-06-10 EP claimed
EP-0188802-A2 Dibenz (b,e) oxepin derivative and antiallergic agent KYOWA HAKKO KOGYO CO., LTD. (JP) 1986-07-30 EP claimed
EP-0185079-A1 CIBA GEIGY AG 1986-06-25 EP claimed
WO-1986000066-A1 N-SUBSTITUTED BUTYRAMIDE DERIVATIVES CIBA-GEIGY AG (CH) 1986-01-03 WO claimed
EP-0061765-B1 BETA-LACTAMS E.R. SQUIBB &amp; SONS, INC. (US) 1985-08-28 EP claimed
US-4478749-A AMINO ACID DERTIVATIVES ANTIBIOTICS E. R. SQUIBB & SONS, INC. (US) 1984-10-23 US claimed
EP-0061765-A1 Beta-Lactams E.R. SQUIBB &amp; SONS, INC. (US) 1982-10-06 EP claimed
JP-61152669-A None JP disclosed
EP-0072013-A1 Pyrrole compounds as anti-inflammatory and analgesic agents MERCK & CO. INC. (US) 1983-02-16 EP disclosed
EP-0061765-A1 Beta-Lactams E.R. SQUIBB &amp; SONS, INC. (US) 1982-10-06 EP disclosed